SMALLER PHARMA COMPANIES WARNED OF UPCOMING EU RULE CHANGES
April 12th, 2014
A BULLETIN designed to advise small and medium-sized companies within the European Union (EU) pharma sector has warned that a European Medicines Agency (EMA) guideline on process validation for finished products will come into effect on June 15 (2014). Published by EMA, the bulletin advises that the new guideline stipulates what process validation data should be submitted in regulatory submissions for finished dosage forms regarding medicines and active substances.See - ...
Full access to this article can be arranged with permission from the client that first ordered it. Please contact us to request access. Entries are uploaded to our archive at least one year after being published by a client – free access is restricted to International News Services journalists for background research only. The article date indicates when copy was filed to a client, not when posted to this archive. Upon client requests, International News Services will remove such articles from the archive or not upload them in the first place. They are included to demonstrate the breadth of topics undertaken by the agency and also to help promote clients’ coverage.